Does LEVETIRACETAM Cause Hypertransaminasaemia? 113 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Hypertransaminasaemia have been filed in association with LEVETIRACETAM (Levetiracetam). This represents 0.2% of all adverse event reports for LEVETIRACETAM.
113
Reports of Hypertransaminasaemia with LEVETIRACETAM
0.2%
of all LEVETIRACETAM reports
10
Deaths
66
Hospitalizations
How Dangerous Is Hypertransaminasaemia From LEVETIRACETAM?
Of the 113 reports, 10 (8.8%) resulted in death, 66 (58.4%) required hospitalization, and 8 (7.1%) were considered life-threatening.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVETIRACETAM. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does LEVETIRACETAM Cause?
Seizure (9,961)
Drug ineffective (8,666)
Off label use (5,789)
Maternal exposure during pregnancy (3,197)
Foetal exposure during pregnancy (2,604)
Epilepsy (2,546)
Generalised tonic-clonic seizure (2,276)
Somnolence (2,070)
Fatigue (1,972)
Status epilepticus (1,883)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)
Which LEVETIRACETAM Alternatives Have Lower Hypertransaminasaemia Risk?
LEVETIRACETAM vs LEVOBUNOLOL
LEVETIRACETAM vs LEVOBUPIVACAINE
LEVETIRACETAM vs LEVOCARNITINE
LEVETIRACETAM vs LEVOCETIRIZINE
LEVETIRACETAM vs LEVODOPA